Tru Independence LLC Biogen Inc. Transaction History

Tru Independence LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $33,675 - $43,916	-119 Closed	0 $0
Q2 2021 Aug 03, 2021	BUY	$259.0 - $414.71 $30,821 - $49,350	119 New	119 $41,000
Q1 2021 May 20, 2021	SELL	$242.95 - $284.63 $22,837 - $26,755	-94 Closed	0 $0
Q4 2020 Mar 09, 2021	BUY	$236.26 - $355.63 $945 - $1,422	4 Added 4.44%	94 $23,000
Q4 2019 May 19, 2020	BUY	$220.06 - $304.07 $19,805 - $27,366	90 New	90 $28,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Tru Independence LLC, based on Form 13F filings with the SEC.

Stay updated on Tru Independence LLC with notifications on news.